首页> 外文学位 >Development, Validation, and Cost Effectiveness of Clinical Prediction Rules for Group A Beta Hemolytic Streptococcal Pharyngitis In Children From Lower and Upper Middle Income Countries.
【24h】

Development, Validation, and Cost Effectiveness of Clinical Prediction Rules for Group A Beta Hemolytic Streptococcal Pharyngitis In Children From Lower and Upper Middle Income Countries.

机译:中低收入国家儿童的A组溶血性链球菌性咽炎临床预测规则的开发,验证和成本效益。

获取原文
获取原文并翻译 | 示例

摘要

Background: An estimated 3% of untreated group A beta hemolytic streptococcal (GABHS) pharyngitis can lead to rheumatic fever (RF), resulting in rheumatic heart disease (RHD) and other serious nonsuppurative sequelae of infection (1-5). Prevalence of disease is disproportionate with the greatest burden among children and adolescents of developing countries; an estimated 95% of RF and 79% of RHD cases are from low income countries (5). Accurate diagnosis and prompt antibiotic treatment of GABHS pharyngitis is a simple and effective strategy for primary prevention of RF and RHD. Accurate diagnosis is difficult without laboratory testing due to similarities in signs and symptoms with other causes of pharyngitis.;Due to financial constraints, laboratory capabilities are often limited, forcing many physicians in low and middle income countries (LMICs) to either prescribe antibiotics indiscriminately or rely on clinical prediction rules (CPRs). CPRs provide a practical alternative for diagnosis in the absence of laboratory testing. However, few CPRs have been derived specifically for LMICs. Studies have shown that CPRs can be cost effective in hospital settings, but few have been conducted for children from LMICs (6, 7).;Methods: Children 2-12 years of age presenting with complaint of sore throat were enrolled in four urban university pediatric outpatient clinics from September 2001 to August 2005 in Rio de Janeiro, Brazil, Cairo, Egypt; Riga Latvia and Zagreb, Croatia. The diagnostic component of the study (Chapters 4-5) consisted of generating CPRs for the 1,993 children enrolled in the study. It also consisted of external validation of a) published CPRs from the literature, and b) study developed CPRs. The cost effectiveness analysis component of the study (Chapter 6) assessed the cost effectiveness of the CPR developed for Egypt versus five alternative diagnostic and management strategies.;Summary: The dissertation consists of findings from three papers (Chapters 4-6). In paper 1 (Chapter 4), five different CPRs were developed for use in Egypt, Brazil, Latvia, Croatia, and the combined study population. In paper 2 (Chapter 5), external validation of published and study CPRs suggested country specific CPRs were better in the population for which they were developed. In paper 3 (Chapter 6), Culture Only was the most cost effective strategy at baseline estimates; however, the Egypt CRP was cost effective when sensitivity and specificity were at or above 88%.
机译:背景:未经治疗的A组β溶血性链球菌(GABHS)咽炎估计有3%会导致风湿热(RF),导致风湿性心脏病(RHD)和其他严重的非化脓性感染后遗症(1-5)。疾病的流行不成比例,在发展中国家的儿童和青少年中负担最重;估计有95%的RF和79%的RHD病例来自低收入国家(5)。准确诊断和及时应用GABHS咽炎的抗生素治疗是一级预防RF和RHD的简单有效策略。由于体征和症状与咽炎的其他原因相似,如果不进行实验室测试,则很难进行准确诊断。由于财务上的限制,实验室的能力通常很有限,迫使中低收入国家(LMIC)的许多医生随意开抗生素或使用抗生素。依靠临床预测规则(CPR)。在没有实验室测试的情况下,心肺复苏术可以提供实用的诊断方法。但是,很少有专门针对LMIC的CPR。研究表明,心肺复苏术在医院环境中具有成本效益,但针对中低收入国家的儿童进行的心肺复苏术很少(6,7);方法:四名城市大学招收了2-12岁患有喉咙痛的儿童2001年9月至2005年8月在巴西里约热内卢,埃及开罗的儿科门诊;里加拉脱维亚和克罗地亚萨格勒布。该研究的诊断部分(第4-5章)包括为参与研究的1,993名儿童生成CPR。它还包括以下方面的外部验证:a)文献中发表的CPR,b)研究已开发的CPR。研究的成本效益分析部分(第6章)评估了针对埃及开发的CPR的成本效益,并提出了五种替代性的诊断和管理策略。总结:论文包括三篇论文的发现(第4-6章)。在论文1(第4章)中,开发了五种不同的CPR,分别用于埃及,巴西,拉脱维亚,克罗地亚和研究人群。在论文2(第5章)中,对已发表和研究的CPR的外部验证表明,针对特定国家的CPR在其开发人群中更好。在论文3(第6章)中,仅文化是基线估算中最具成本效益的策略。但是,当敏感性和特异性达到或超过88%时,埃及CRP便具有成本效益。

著录项

  • 作者

    Assefa, Mehret Tsega.;

  • 作者单位

    University of California, Los Angeles.;

  • 授予单位 University of California, Los Angeles.;
  • 学科 Health Sciences Epidemiology.;Health Sciences General.
  • 学位 Ph.D.
  • 年度 2014
  • 页码 335 p.
  • 总页数 335
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号